Archives

img-01

Japan Discusses More Support for Orphan Drugs

On January 13, various members of the Japanese Health Ministry met and discussed the need to improve orphan drug designation and approval. Increased funding for orphan drug development was debated. Orphan drug designation (ODD) can be achieved in the West with Phase... Read More

img-01

Asia CDx Market Taking Off

While still behind the US and EU CDx markets to date, over the next 5 years, more and more CDx’s will be registered and used for precision medicine in Asia. Drug companies doing clinical trials and launching new drugs in Asia will... Read More

img-01

Japan CDx Registration

Pacific Bridge Medical has worked with a number of Western CDx companies to address the above issues and register CDx products in Japan. Please contact us to learn more. As medical care becomes more personalized, more drug companies are looking to utilize... Read More